Open Access

Lipo‑prostaglandin E1 modifies cognitive impairment in rats with vascular cognitive impairment by promoting angiogenesis via the VEGF/VEGFR pathway

  • Authors:
    • Bohui Liu
    • Suping Zhang
    • Xifeng Xiong
    • Li Ling
    • Rui He
    • Muzhen Wang
    • Wanqing Deng
    • Zhihe Liu
    • Yi Li
  • View Affiliations

  • Published online on: July 14, 2017     https://doi.org/10.3892/mmr.2017.6984
  • Pages: 3117-3124
  • Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The pathological mechanism of vascular cognitive impairment (VCI) involves ischemic lesions in the hippocampus. Prostaglandin E1 (PGE1) serves roles in the promotion of vascular endothelial growth factor (VEGF) expression, angiogenesis and enhances blood flow to ischemic regions. However, the effect of PGE1 on cognitive function in VCI rats and the underlying mechanism are unknown. In the current study, learning and memory function in VCI rats treated by lipo‑PGE1 injection was assessed through Morris Water Maze test. Furthermore, the histological alterations, blood vessel numbers in the hippocampal CA1 region and relative VEGF protein and mRNA expression were researched. The results confirmed that VCI rats treated with lipo‑PGE1 presented improved cognitive function, less neuronal cell loss, a greater number of blood vessels in the hippocampal region and higher VEGF protein and mRNA expression. However, the role of lipo‑PGE1 in VCI rats can be inhibited by SU5416 (a specific VEGFR2 antagonist). The results indicated that lipo‑PGE1 may alleviate cognitive deficits in VCI rats. The underlying mechanism may be associated with angiogenesis promoted by lipo‑PGE1, which may involve the VEGF/VEGFR pathway. These findings may have therapeutic implications for cognitive impairment induced by hypoperfusion or chronic ischemic lesions.
View Figures
View References

Related Articles

Journal Cover

September-2017
Volume 16 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu B, Zhang S, Xiong X, Ling L, He R, Wang M, Deng W, Liu Z and Li Y: Lipo‑prostaglandin E1 modifies cognitive impairment in rats with vascular cognitive impairment by promoting angiogenesis via the VEGF/VEGFR pathway. Mol Med Rep 16: 3117-3124, 2017.
APA
Liu, B., Zhang, S., Xiong, X., Ling, L., He, R., Wang, M. ... Li, Y. (2017). Lipo‑prostaglandin E1 modifies cognitive impairment in rats with vascular cognitive impairment by promoting angiogenesis via the VEGF/VEGFR pathway. Molecular Medicine Reports, 16, 3117-3124. https://doi.org/10.3892/mmr.2017.6984
MLA
Liu, B., Zhang, S., Xiong, X., Ling, L., He, R., Wang, M., Deng, W., Liu, Z., Li, Y."Lipo‑prostaglandin E1 modifies cognitive impairment in rats with vascular cognitive impairment by promoting angiogenesis via the VEGF/VEGFR pathway". Molecular Medicine Reports 16.3 (2017): 3117-3124.
Chicago
Liu, B., Zhang, S., Xiong, X., Ling, L., He, R., Wang, M., Deng, W., Liu, Z., Li, Y."Lipo‑prostaglandin E1 modifies cognitive impairment in rats with vascular cognitive impairment by promoting angiogenesis via the VEGF/VEGFR pathway". Molecular Medicine Reports 16, no. 3 (2017): 3117-3124. https://doi.org/10.3892/mmr.2017.6984